Public source

Reviewed 21 Jul 2026

Completeness Good (42%)

Paige Prostate Grade & Quantify

Paige

Paige Prostate Grade & Quantify is offered and sold as part of the Paige Prostate Suite. Categorizes areas suspicious for cancer by Gleason pattern, providing a primary and secondary Gleason grade prediction, as well as a percentage and linear measurement of tumor burden.

For use with digitized H&E stained prostate needle biopsy images. A qualified pathologist should employ appropriate procedures to ensure the quality of the images and use manual visualization and re-evaluate the product’s result before incorporation into the final diagnosis. The results shall only be considered after a pathologist’s initial review of the entire WSI.

Performance: Validated on a set of 1,000 prostate images. Slide level ISUP/Grade Group classification linear-weighted Kappa concordance was 0.78, slide level tumor length Pearson correlation coefficient was 0.83 and slide level tumor percentage Pearson correlation coefficient was 0.91.

Supported by 2 papers

Key features

Prostate cancer grading

General Information

Product name

Paige Prostate Grade & Quantify

Company

Modality

Histopathology

Main task

Grading, Quantification

Subspeciality

Uropathology

Organ/Specimen source

Not specified

Disease targeted

Prostate cancer

Specimen type

Biopsy

Staining

H&E

Stain subtype

Not specified

Regulatory Information

CE-IVD Certification

Pathway:

In Vitro Diagnostic Directive (IVDD)

Class:

General IVD Devices

Not verified by Health AI Register

Scanner Brands Certified for Use (CE-IVD)

Leica, Philips

Scanner Models Certified for Use (CE-IVD)

Not specified

Other certifications

Not specified

Technical Specifications

Patient population age

Not specified

Input

Not specified

Input format

Not specified

Output

Not specified

Output format

Not specified

Integration

Integration via AI marketplace or distribution platform

Deployment

Not specified

Trigger for analysis

Not specified

Processing time

Not specified

Population

Not specified

Viewer systems

FullFocus (Paige)

Market Presence

On market since

Not specified

AI Platforms

Sectra Amplifier Store

Resellers

Not specified

Countries present

Not specified

Paying clinical customers

Not specified

Research/test users

Not specified

Pricing Information

Pricing model

Subscription

Based on

Not specified

Source: Public | First published: Aug 1, 2025 | Last updated: Jul 21, 2026